Covaxin gets SEC approval: Getting the experts’ perspective, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

If granted approval by DCGI, Covaxin will become only the second vaccine after Zydus Cadila’s ZyCoV-D to be granted permission for inoculating children in 2-18 age group., If granted approval by DCGI, Covaxin will become only the second vaccine after Zydus Cadila’s ZyCoV-D to be granted permission for inoculating children in 2-18 age group., , Read More